Biosensor– tag –
-
Wearable Sweat Patches Expand CF Diagnosis: Smartphone Integration Reduces Lab Dependency
ICT&health Netherlands Overview Researchers at Northwestern University and Ann & Robert H. Lurie Children's Hospital developed a novel wearable patch system to replace traditional sweat tests for cystic fibrosis (CF) diagnosis with a... -
University of Houston Establishes Digital Healthcare Transformation Institute: Accelerating AI, Wearables, and Biosensors in Medical Innovation
University of Houston USA Overview The University of Houston has launched its Digital Healthcare Transformation Institute to accelerate research, development, and commercialization of next-generation technologies like AI-driven diagnosti... -
Synergistic Nanocomposites Enhance Multiplex Biomarker Detection: Achieving High-Performance Glucose Sensing with Microfluidic Integration
Analytical Chemistry (ACS Publications) USA Overview Synergistic nanocomposite-enabled biosensors offer a promising strategy for multiplex biomarker detection in optical and electrochemical sensing. Sensors incorporating laser-induced gr... -
Graphene Field-Effect Transistor Biosensors Advance Clinical Applications: Enabling Label-Free, High-Sensitivity Disease Biomarker Detection
PMC Switzerland Overview Graphene Field-Effect Transistor (GFET) biosensors are emerging as a promising platform for early disease diagnosis due to their high sensitivity, label-free detection, and compatibility with point-of-care testin... -
Philips Expands Open Patient Monitoring Ecosystem, Bolstering Continuous Biomarker Surveillance Beyond the Bedside
Philips Netherlands Overview Philips significantly expanded its open patient monitoring ecosystem through collaborations with multiple partners including Respiree, smartQare, and LifeSignals. This initiative deploys wearable biosensor te... -
Dexcom Achieves 13% Q2 Revenue Growth as FDA Approves OTC Glucose Biosensor Stelo for Pediatric Use
Medical Design and Outsourcing USA Overview Dexcom reported a robust 13% year-over-year revenue growth in Q2 2026, demonstrating the efficacy of its CGM technology in non-insulin-using Type 2 diabetes patients. Concurrently, the U.S. FDA... -
POCT Innovations Accelerate at MEDICA 2026: Biosensors, Imaging AI, and Lab-on-a-Chip Drive Precision Medicine
MEDICA Germany Overview MEDICA 2026 highlights significant advancements in Point-of-Care Testing (POCT), accelerating on-site diagnostics for rapid clinical decision-making. Progress in biosensors, imaging AI, biomarkers, and lab-on-a-ch... -
Dexcom Expands Beyond Diabetes Sensors to Comprehensive Health Platform with G8 Launch, Stelo Introduction, and FDA TEMPO Program Inclusion
Libre Life USA Overview Dexcom is transforming from a diabetes sensor manufacturer into a broader connected health platform, marked by the announcement of its next-gen G8 CGM, a 15-day wear extension for G7 internationally, and the launc... -
Biosensors & POCT Weekly Report August 2, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report August 02, 2026 (PDF) — Download Weekly Report August 02, 2026 (PDF) — DownloadDownload 🎙 Podcast August 02, ... -
Biosphere CRO Identifies 2026 Clinical Trial Trends: AI, Wearable Biosensors Accelerate Drug Development
Biosphere CRO International Overview Biosphere CRO reports that 2026 clinical trials are being transformed by the maturation of AI, remote monitoring infrastructure, wearable biosensors, and cloud-native data platforms. These technologie...
